International Journal of Hepatology

Metastatic lesions to the Liver


Publishing date
17 May 2013
Status
Published
Submission deadline
28 Dec 2012

Lead Editor

1Department of Surgery, Albert Einstein Medical Center, Philadelphia, PA 19002, USA

2Department of Surgery, University of California at Irvine, Irvine, CA 92697, USA

3Department of Surgery, University of Pittsburgh Medical Center Italy, ISMETT, Palermo, Italy

4Downstate Medical Center, Brooklyn, NY, USA

5Department of Surgery, Montefiore Medical Center, New York, NY 100467, USA


Metastatic lesions to the Liver

Description

Many cancers metastasize to the liver and may be amenable to interventional, medical, and surgical interventions. These include sarcoma, neuroendocrine masses, breast and stomach cancer, renal cancer, and colon and rectal cancer. Recent advances in biology and medicine have introduced new technologies that have revitalized the diagnosis and treatment of metastatic disease to the liver.

We invite investigators to contribute original research articles as well as review articles that will stimulate further growth and innovation which will hopefully lead to further understanding of the metastatic disease process and possible interventions for cure.

We welcome submissions from oncologists, surgeons, radiologists, and hepatologists. We are particularly interested in new modalities of treatment. Potential topics include, but are not limited to:

  • New surgical indications for various metastatic lesions
  • New surgical techniques
  • Radiofrequency ablation, chemoembolization, and other interventional maneuvers used for treatment
  • Radiologic (and other tests) utilized for diagnosis
  • The potential role of PET scans
  • New chemotherapeutics
  • The role of transplantation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijhep/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ijhep/lesion/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 104365
  • - Editorial

Metastatic Lesions to the Liver

Jorge Ortiz | David K. Imagawa | ... | Liise K. Kayler
  • Special Issue
  • - Volume 2013
  • - Article ID 141590
  • - Review Article

Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases

Yi-Hsin Liang | Yu-Yun Shao | ... | Zhong-Zhe Lin
  • Special Issue
  • - Volume 2013
  • - Article ID 572307
  • - Review Article

Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon’s Perspective!

Kelly J. Lafaro | Panayota Roumanis | ... | David K. Imagawa
  • Special Issue
  • - Volume 2013
  • - Article ID 314868
  • - Clinical Study

A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics

Eric Nguyen-Khac | Céline Lobry | ... | Jean Marc Regimbeau
  • Special Issue
  • - Volume 2013
  • - Article ID 235040
  • - Review Article

Surgical Treatment and Survival in Patients with Liver Metastases from Neuroendocrine Tumors: A Meta-Analysis of Observational Studies

Stefano Bacchetti | Serena Bertozzi | ... | Enrico Maria Pasqual
  • Special Issue
  • - Volume 2012
  • - Article ID 870306
  • - Clinical Study

Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence

Petra G. Kele | Eric J. Van der Jagt | ... | Koert P. de Jong
International Journal of Hepatology
 Journal metrics
See full report
Acceptance rate13%
Submission to final decision111 days
Acceptance to publication21 days
CiteScore3.400
Journal Citation Indicator0.480
Impact Factor1.8
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.